Skip to content
healthcare.dev

Headache Relief Extra Strength

NDC 59726-586, Acetaminophen, Aspirin, Caffeine, tablet, coated, from P & L Development, LLC.

Product NDC
59726-586
Status
Listed
Labeler
P & L Development, LLC
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59726-586 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN250 mg/1
  • ASPIRIN250 mg/1
  • CAFFEINE65 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
59726-586-80597260586801 BOTTLE, PLASTIC in 1 BOTTLE (59726-586-80) / 80 TABLET, COATED in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 59726-586 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59726-586 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59726-586. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.